Bhaskar Chaudhuri's most recent trade in Arcutis Biotherapeutics Inc was a trade of 20,568 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,568 | 20,568 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,609 | 867,826 (2%) | 0% | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 4,540 | 4,540 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 8,700 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,954 | 2,954 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 5,350 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 10,139 | 860,217 (2%) | 0% | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 2,000 | - | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,220 | 12,220 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 4,375 | 850,078 (2%) | 0% | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,796 | 11,796 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,312 | 845,703 (2%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 24 Jun 2021 | 6,755 | 841,391 (2%) | 0% | 27.5 | 185,763 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 24 Jun 2021 | 729 | 848,146 (2%) | 0% | 27.5 | 20,048 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 21 Jun 2021 | 2,516 | 848,875 (2%) | 0% | 27.5 | 69,190 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 13,391 | 13,391 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 01 Jun 2021 | 10,000 | 851,391 (2%) | 0% | 27.5 | 275,000 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.99 per share. | 20 Apr 2021 | 8,720 | 862,671 (2%) | 0% | 28.0 | 244,053 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 20 Apr 2021 | 1,280 | 861,391 (2%) | 0% | 28.5 | 36,515 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 30.77 per share. | 22 Mar 2021 | 5,008 | 876,383 (2%) | 0% | 30.8 | 154,115 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 31.43 per share. | 22 Mar 2021 | 4,992 | 871,391 (2%) | 0% | 31.4 | 156,906 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 35.34 per share. | 22 Feb 2021 | 7,211 | 884,180 (2%) | 0% | 35.3 | 254,866 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 35.97 per share. | 22 Feb 2021 | 2,789 | 881,391 (2%) | 0% | 36.0 | 100,325 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 33.25 per share. | 29 Jan 2021 | 9,949 | 891,391 (2%) | 0% | 33.2 | 330,804 | Common Stock |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 29 Jan 2021 | 51 | 901,340 (2%) | 0% | 27.5 | 1,403 | Common Stock |